Your browser doesn't support javascript.
loading
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial.
Dieci, M V; Prat, A; Tagliafico, E; Paré, L; Ficarra, G; Bisagni, G; Piacentini, F; Generali, D G; Conte, P; Guarneri, V.
Affiliation
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy mariavittoria.dieci@unipd.it.
  • Prat A; Translational Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona Translational Genomic and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Tagliafico E; Center for Genome Research, University of Modena and Reggio Emilia, Modena.
  • Paré L; Translational Genomic and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona.
  • Ficarra G; Division of Pathology, Modena University Hospital, Modena.
  • Bisagni G; Department of Medical Oncology, Azienda Ospedaliera ASMN, IRCCS, Reggio Emilia.
  • Piacentini F; Department of Medical and Surgical Sciences of Mother, Child and Adult, University of Modena and Reggio Emilia, Modena.
  • Generali DG; U.O. Multidisciplinare di Patologia Mammaria, AO. Istituti Ospitalieri di Cremona, Cremona, Italy.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Ann Oncol ; 27(10): 1867-73, 2016 10.
Article in En | MEDLINE | ID: mdl-27484801
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: